SCHEMBL6922197

SCHEMBL6922197

C=CCOc1ccccc1C(=O)C=O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIG1 P18858 1/20 0.65
TSHR P16473 3/20 0.51
HSD17B10 Q99714 2/20 0.51
HPGD P15428 2/20 0.51
MAPK1 P28482 1/20 0.51
CYP3A4 P08684 2/20 0.50
KDM4E B2RXH2 1/20 0.49
ADRB2 P07550 2/20 0.48
ADRB1 P08588 2/20 0.48
ADRB3 P13945 1/20 0.48
GAA P10253 3/20 0.48
ALDH1A1 P00352 2/20 0.44
FLT3 P36888 1/20 0.43
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
SLC22A1 O15245 1/20 0.40
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40
HTR1A P08908 1/20 0.40
CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9696302 0.84 LIG1 (0.71) LIG1TSHRHSD17B10HPGDMAPK1
SCHEMBL40310 0.83 LIG1 (0.69) LIG1TSHRHSD17B10HPGDMAPK1
SCHEMBL29519569 0.83 LIG1 (0.69) LIG1TSHRHSD17B10HPGDMAPK1
SCHEMBL132849 0.82 LIG1 (0.63) LIG1TSHRHSD17B10HPGDMAPK1
SCHEMBL2788250 0.81 LIG1 (0.67) LIG1TSHRHSD17B10HPGDMAPK1
Zinc Ion SCHEMBL2788244 0.81 LIG1 (0.67) LIG1TSHRHSD17B10HPGDMAPK1
SCHEMBL1426602 0.81 LIG1 (0.67) LIG1TSHRHSD17B10HPGDMAPK1
SCHEMBL1889645 0.81 LIG1 (0.67) LIG1TSHRHSD17B10HPGDMAPK1
SCHEMBL1428 0.81 LIG1 (0.67) LIG1TSHRHSD17B10HPGDMAPK1
SCHEMBL7794511 0.81 LIG1 (0.67) LIG1TSHRHSD17B10HPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6673969-B2 REACTING MIXTURE OF ALKYL-SALICYL-ALDEHYDES OR ALKYL-SALICYL-KETONES WITH HYDROXYLAMINE SULFATE OR HYDROXYLAMINE HYDROCHLORIDE; FOR EXTRACTING GALLIUM FROM WASTE EFFLUENTS FROM ORE PROCESSING, SUCH AS BAYER LIQUOR COMSELHO NACIONAL DE DESENVOLVIMENTO CIENTIFICO E TECNOLOGICO CNPQ (BR) 2004-01-06 US claimed
US-20020123650-A1 Process for preparation of oximes and resulting products CETEM - CENTRO DE TECNOLOGIA MINERAL (BR) 2002-09-05 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020123650-A1 Process for preparation of oximes and resulting products ACHE, LPO, GALE LIG1 949/4885TSHR 1579/4885HSD17B10 1770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.